Skip to content

Integration of Palliative Care in an Oncology and Hematology Unit

Integration of Palliative Care in an Oncology and Hematology Unit : a Retrospective Monocentric Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04089306
Enrollment
100
Registered
2019-09-13
Start date
2019-10-01
Completion date
2020-05-31
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Keywords

Advanced Cancer, End of Life, Agressiveness of Care, Palliative Care integration

Brief summary

The main goal of this study is to assess retrospectively the integration of Palliative Care in an oncology and hematology unit. The investigators will study the last six month of life on advanced cancer patients and retrieve data from their medical file to obtain criterias of quality of care and integration of palliative care in this population. Those criterias have been used before in other setting (Earle Criterias, ESMO Recommendations) and The investigators will compare our data to existing publications. They also hope to see if it is retrospectively possible to assess the probability of death using the Pronopall score. This will help them asses if aggressive end of life care could have been avoided using the Pronopall Score

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient aged over 18 years old * Patient who has been followed in the oncohematology Unit of the University Hospital of Strasbourg for a solid tumor or haematological cancer * Died within the 1rst of January 2017 and the 31st of December 2018 * The patient has not expressed an opposition to the use of his medical data during his lifetime.

Exclusion criteria

* Patient receiving allogeneic stem cell transplant * Patient expressed during his lifetime an opposition regarding the use of his medical data

Design outcomes

Primary

MeasureTime frame
Retrospective study of palliative care in oncohematology departmentThe period from January 1st, 2017 to December 31, 2018 will be examined

Countries

France

Contacts

Primary ContactGabriel MALOUF, MD, PhD
gabriel.malouf@chru-strasbourg.fr03 88 11 62 22

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026